BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27401384)

  • 1. [Association between microRNA single nucleotide polymorphisms and the risk of hepatocellular carcinoma].
    Li W; Ma Y; Zeng D; Zhang J; Wang R; Hu J; Yang D; Hu H; Wang J; Liu J
    Rev Med Chil; 2016 Apr; 144(4):508-15. PubMed ID: 27401384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
    Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
    Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
    Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
    Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
    J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
    Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Üsküdar O
    Asian Pac J Cancer Prev; 2011; 12(11):3107-12. PubMed ID: 22393998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association study of miR‑149 rs2292832 and miR‑608 rs4919510 and the risk of hepatocellular carcinoma in a large‑scale population.
    Wang R; Zhang J; Ma Y; Chen L; Guo S; Zhang X; Ma Y; Wu L; Pei X; Liu S; Wang J; Hu H; Liu J
    Mol Med Rep; 2014 Nov; 10(5):2736-44. PubMed ID: 25190221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
    Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
    Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population.
    Wang XH; Wang FR; Tang YF; Zou HZ; Zhao YQ
    Genet Mol Res; 2014 Jul; 13(3):5048-54. PubMed ID: 25061729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity.
    Wu X; Xin Z; Zhang W; Wu J; Chen K; Wang H; Zhu X; Pan L; Li Z; Li H; Liu Y
    Int J Cancer; 2013 Sep; 133(5):1085-93. PubMed ID: 23404364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil.
    Teixeira AC; Mendes CT; Marano LA; Deghaide NH; Secaf M; Elias J; Muglia V; Donadi EA; Martinelli AL
    Hum Immunol; 2013 Aug; 74(8):1024-9. PubMed ID: 23632060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.
    Wang B; Xu Q; Yang HW; Sun LP; Yuan Y
    Oncotarget; 2016 Apr; 7(15):20357-67. PubMed ID: 26967386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients.
    Segat L; Milanese M; Pirulli D; Trevisiol C; Lupo F; Salizzoni M; Amoroso A; Crovella S
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1840-6. PubMed ID: 19817957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
    Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
    Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of PNPLA3 and JAZF1 on hepatocellular carcinoma in non-viral hepatitis patients with type 2 diabetes mellitus.
    Ueyama M; Nishida N; Korenaga M; Korenaga K; Kumagai E; Yanai H; Adachi H; Katsuyama H; Moriyama S; Hamasaki H; Sako A; Sugiyama M; Aoki Y; Imamura M; Murata K; Masaki N; Kawaguchi T; Torimura T; Hyogo H; Aikata H; Ito K; Sumida Y; Kanazawa A; Watada H; Okamoto K; Honda K; Kon K; Kanto T; Mizokami M; Watanabe S
    J Gastroenterol; 2016 Apr; 51(4):370-9. PubMed ID: 26337813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma.
    Wang Q; Yu X; Li Q; Qin L; Tan S; Zeng X; Qiu X; Tang B; Jin J; Liao W; Qiu M; Tan L; He G; Li X; He S; Yu H
    Oncotarget; 2016 Nov; 7(48):79365-79371. PubMed ID: 27813498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population.
    Xu X; Ling Q; Wang J; Xie H; Wei X; Lu D; Hu Q; Zhang X; Wu L; Zhou L; Zheng S
    Int J Cancer; 2016 Feb; 138(3):620-9. PubMed ID: 26365437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between microRNA-196A2 and microRNA-146A polymorphisms and progression to cirrhosis and hepatocellular carcinoma in patients with viral hepatitis B.
    Riazalhosseini B; Mohamed Z; Apalasamy YD; Eng HS; Mohamed R
    Pharmacogenet Genomics; 2016 Feb; 26(2):74-9. PubMed ID: 26529280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma.
    Kim MN; Kim JO; Lee SM; Park H; Lee JH; Rim KS; Hwang SG; Kim NK
    PLoS One; 2016; 11(9):e0162279. PubMed ID: 27611467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.